1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global HIV Diagnosis Market, By Product
5.1 Introduction
5.2 Software & Services
5.3 Instruments
5.4 Consumables
5.4.1 Assays and Kits & Reagents
5.4.2 Other Consumables
6 Global HIV Diagnosis Market, By Test Type
6.1 Introduction
6.2 Antibody Tests
6.2.1 HIV-1 Screening Tests
6.2.1.1 Elisa
6.2.1.2 Home Access Dried Blood Spots
6.2.1.3 Rapid Tests
6.2.2 HIV-1 Antibody Confirmatory Tests
6.2.2.1 Western Blot Tests
6.2.2.2 Line Immunoassays
6.2.2.3 Indirect Immunofluorescence Assays (IFA)
6.2.2.4 Radio-Immunoprecipitation Assays
6.2.3 HIV-2 & Group O Diagnostic Tests
6.3 Viral Load Tests
6.4 Tests for Early Infant Diagnosis
6.5 CD4 Tests
6.6 Tests for Viral Identification
7 Global HIV Diagnosis Market, By End User
7.1 Introduction
7.2 Hospitals & Clinics
7.3 Diagnostic Laboratories
7.4 Home Settings
7.5 Other End Users
8 Global HIV Diagnosis Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abbott Laboratories
10.2 Roche Diagnostics
10.3 Merck KGaA
10.4 Siemens Healthineers
10.5 Thermo-Fisher Scientific Inc.
10.6 Beckman Coulter, Inc.
10.7 Hologic Inc.
10.8 Becton, Dickinson & Company
10.9 Bio-Rad Laboratories
10.10 Alere Inc.
10.11 OraSure Technologies, Inc.
10.12 Zyomyx Incorporation
10.13 Chembio Diagnostic Systems, Inc.
10.14 Janssen Pharmaceutica NV
10.15 Bristol –Myers Squibb
List of Tables
Table 1 Global HIV Diagnosis Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 4 Global HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 5 Global HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 6 Global HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 7 Global HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 8 Global HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 9 Global HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 10 Global HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 11 Global HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 12 Global HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 13 Global HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 14 Global HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 15 Global HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 16 Global HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 17 Global HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 18 Global HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 19 Global HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 20 Global HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 21 Global HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 22 North America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 23 North America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 24 North America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 25 North America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 26 North America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 27 North America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 28 North America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 29 North America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 30 North America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 31 North America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 32 North America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 33 North America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 34 North America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 35 North America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 36 North America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 37 North America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 38 North America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 39 North America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 40 North America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 41 North America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 42 North America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 43 Europe HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 44 Europe HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 45 Europe HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 46 Europe HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 47 Europe HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 48 Europe HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 49 Europe HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 50 Europe HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 51 Europe HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 52 Europe HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 53 Europe HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 54 Europe HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 55 Europe HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 56 Europe HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 57 Europe HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 58 Europe HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 59 Europe HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 60 Europe HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 61 Europe HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 62 Europe HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 63 Europe HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 64 Asia Pacific HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 65 Asia Pacific HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 66 Asia Pacific HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 67 Asia Pacific HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 68 Asia Pacific HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 69 Asia Pacific HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 70 Asia Pacific HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 71 Asia Pacific HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 72 Asia Pacific HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 73 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 74 Asia Pacific HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 75 Asia Pacific HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 76 Asia Pacific HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 77 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 78 Asia Pacific HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 79 Asia Pacific HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 80 Asia Pacific HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 81 Asia Pacific HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 82 Asia Pacific HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 83 Asia Pacific HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 84 Asia Pacific HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 85 South America HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 86 South America HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 87 South America HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 88 South America HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 89 South America HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 90 South America HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 91 South America HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 92 South America HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 93 South America HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 94 South America HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 95 South America HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 96 South America HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 97 South America HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 98 South America HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 99 South America HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 100 South America HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 101 South America HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 102 South America HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 103 South America HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 104 South America HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 105 South America HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
Table 106 Middle East & Africa HIV Diagnosis Market Outlook, By Country (2021-2030) ($MN)
Table 107 Middle East & Africa HIV Diagnosis Market Outlook, By Product (2021-2030) ($MN)
Table 108 Middle East & Africa HIV Diagnosis Market Outlook, By Software & Services (2021-2030) ($MN)
Table 109 Middle East & Africa HIV Diagnosis Market Outlook, By Instruments (2021-2030) ($MN)
Table 110 Middle East & Africa HIV Diagnosis Market Outlook, By Consumables (2021-2030) ($MN)
Table 111 Middle East & Africa HIV Diagnosis Market Outlook, By Assays and Kits & Reagents (2021-2030) ($MN)
Table 112 Middle East & Africa HIV Diagnosis Market Outlook, By Other Consumables (2021-2030) ($MN)
Table 113 Middle East & Africa HIV Diagnosis Market Outlook, By Test Type (2021-2030) ($MN)
Table 114 Middle East & Africa HIV Diagnosis Market Outlook, By Antibody Tests (2021-2030) ($MN)
Table 115 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Screening Tests (2021-2030) ($MN)
Table 116 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-1 Antibody Confirmatory Tests (2021-2030) ($MN)
Table 117 Middle East & Africa HIV Diagnosis Market Outlook, By HIV-2 & Group O Diagnostic Tests (2021-2030) ($MN)
Table 118 Middle East & Africa HIV Diagnosis Market Outlook, By Viral Load Tests (2021-2030) ($MN)
Table 119 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Early Infant Diagnosis (2021-2030) ($MN)
Table 120 Middle East & Africa HIV Diagnosis Market Outlook, By CD4 Tests (2021-2030) ($MN)
Table 121 Middle East & Africa HIV Diagnosis Market Outlook, By Tests for Viral Identification (2021-2030) ($MN)
Table 122 Middle East & Africa HIV Diagnosis Market Outlook, By End User (2021-2030) ($MN)
Table 123 Middle East & Africa HIV Diagnosis Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 124 Middle East & Africa HIV Diagnosis Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
Table 125 Middle East & Africa HIV Diagnosis Market Outlook, By Home Settings (2021-2030) ($MN)
Table 126 Middle East & Africa HIV Diagnosis Market Outlook, By Other End Users (2021-2030) ($MN)
| ※参考情報 HIV診断は、ヒト免疫不全ウイルス（HIV）感染の有無を確認するための医療行為です。HIVは免疫システムを攻撃し、進行すると後天性免疫不全症候群（エイズ）を引き起こすウイルスです。早期の診断は、感染者が適切な治療を受ける機会を得るために極めて重要です。HIV診断の方法としては、主に血液を使用した検査が用いられますが、それ以外にも唾液検査や尿検査もあります。 HIV診断には主に2つの種類があります。一つは抗体検査で、もう一つは抗原検査です。抗体検査は、体内にHIVに対抗する抗体が生成されているかどうかを調べます。この検査は感染後おおよそ2週間から3ヶ月間の間に結果が現れるため、具体的には感染初期における検出が難しい場合があります。抗体検査は一般的に高い精度を持ち、安全で比較的低コストです。 一方、抗原検査はHIVウイルスそのものの存在を確認するための検査で、感染初期段階でも結果が得られることが特徴です。抗原検査は感染から1週間ほどで結果が得られる場合があります。このように、診断の種類によって、感染初期段階の発見や治療のタイミングが異なりますので、患者の状態や検査の目的に応じて適切な方法を選択する必要があります。 HIV感染の診断は、通常以下のような用途に利用されます。最も基本的な用途は、感染の有無を確認することです。感染が確認されると、治療の開始が推奨され、抗レトロウイルス療法（ART）が受けられます。この治療はウイルス量を抑え、免疫機能を維持するために重要です。また、HIV陽性者の血液を介して他者に感染を広めることを防ぐため、早期診断と健康管理が求められます。 さらに、高リスク群に対する定期的な検査は、HIV感染の拡大を防ぐために非常に重要です。たとえば、性感染症のリスクが高い人々や、注射器を共有する利用者は、定期的なHIV検査が推奨されます。診断を通じて感染者を早期に把握することによって、感染拡大を抑制することが可能になります。 最近では、HIV診断に関する技術の進歩が見られます。迅速診断キットの登場により、医療機関を訪れずとも、自宅で簡単に検査を行うことができるようになっています。こうした自己検査は、プライバシーを重視したいと考える人々にとって、非常に大きな利点となります。このような技術は、HIV診断のアクセス性を高めると同時に、感染の早期発見に寄与します。 また、最近の研究では、ウイルスの遺伝子解析を通じて、特定の型のHIVウイルスを識別することが試みられています。これにより、感染経路や流行の傾向を把握することが可能になり、公共の健康対策に向けた有効な手法となるかもしれません。この技術の発展は、将来のHIV対策において非常に重要な役割を担うと考えられています。 総じて、HIV診断は感染の有無を確認し、適切な治療を行うための重要なプロセスです。検査技術の進歩により、より迅速で柔軟な診断が可能になってきています。今後の研究や技術革新が進むことで、HIV感染の予防や治療のさらなる促進が期待されます。感染者がより健康的な生活を送れる環境の構築に寄与することが、今後の課題となるでしょう。HIVに対する理解と周囲の支援を通じて、感染の拡大を防ぎ、より多くの人々が健康を維持できる社会を目指していくことが必要です。 |
